Axelar Patents – Key Insights and Stats

Axelar has a total of 92 patents globally, out of which 29 have been granted. Of these 92 patents, 10% patents are active. Europe is where Axelar has filed the maximum number of patents, followed by United States Of America and Japan. Parallelly, United States Of America seems to be the main focused R&D center and is also the origin country of Axelar.

Axelar was founded in 2003. Axelar operates as a drug development company. The Company offers anti-cancer medications to small-molecule compounds that inhibit the insulin-like growth factor-1 (IGF-1) receptor for treatment of IGF-1 receptor-dependent diseases.

Do read about some of the most popular patents of Axelar which have been covered by us in this article and also you can find Axelar patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Axelar patent portfolio.

How many patents does the CEO of Axelar have?

The CEO, Carl Harald Janson has 0 patents.

How many patents does Axelar have?

Axelar has a total of 92 patents globally. These patents belong to 10 unique patent families. Out of 92 patents, 10 patents are active.

How Many Patents did Axelar File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAxelar Applications FiledAxelar Patents Granted
201022
2011281
20121
201381
201413
20151
20162
20174
201811

How many Axelar patents are Alive/Dead?

Worldwide Patents

How Many Patents did Axelar File in Different Countries?

Countries in which Axelar Filed Patents

CountryPatents
Europe12
United States Of America12
Japan8
China8
Australia7
Canada7
Korea (South)5
Hong Kong (S.A.R.)3
Germany2
New Zealand2
Israel2
Norway2
India2
Singapore1
Spain1
Brazil1
Mexico1
Russia1
Chile1
Austria1
Denmark1
Poland1
Portugal1

Where are Research Centers of Axelar Patents Located?

10 Best Axelar Patents

WO2002102805A1 is the most popular patent in the Axelar portfolio. It has received 60 citations so far from companies like Biovitrum Ab and Osi Pharmaceuticals.

Below is the list of 10 most cited patents of Axelar:

Publication NumberCiatation Count
WO2002102805A160
US20100227797A152
WO2007097707A127
US7348358B216
US7662851B211
US20070123491A111
US7629381B210
CN101389326A8
US20040167208A17
US20130331445A16

What Percentage of Axelar US Patent Applications were Granted?

Axelar (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 37.50%.

Below are the key stats of Axelar patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Axelar?

Law FirmTotal ApplicationsSuccess Rate
Gtc Law Group5689.66%
Tina M Lessani2100.00%
David Newman1100.00%
Fox Rothschild1100.00%
Grayrobinson1100.00%
Logical Semantics1100.00%
Pierce Atwood1100.00%
Platinum Intellectual Property10%

EXCLUSIVE INSIGHTS COMING SOON!

What are Axelar key innovation segments?

What Technologies are Covered by Axelar?

The chart below distributes patents filed by Axelar in different countries on the basis of the technology protected in patents. It also represents the markets where Axelar thinks it’s important to protect particular technology inventions.

R&D Focus: How has Axelar search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Axelar?

Table of Content

Insights you may find interesting

Related Articles

Schock Patents – Insights & Stats (Updated 2024)

Schock has a total of 395 patents globally, out of which 241 have been granted. Of these 395 patents, more than 62% patents are active. Germany is where Schock has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, Germany seems to be the main focused

Read More »

Normet Patents – Insights & Stats (Updated 2024)

Normet has a total of 164 patents globally, out of which 121 have been granted. Of these 164 patents, more than 87% patents are active. Europe (EPO) is where Normet has filed the maximum number of patents, followed by Australia and Canada. Parallelly, Finland seems to be the main focused

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.